Prevalence and Antibiotic Resistance Patterns of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa Isolated from Patients in a Hospital in Zabol, Southeast of Iran

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 69

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-9-3_004

تاریخ نمایه سازی: 29 مهر 1402

چکیده مقاله:

Aims: Treatment of infections caused by metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa (P. aeruginosa) is a major healthcare-associated concern. Therefore, the purpose of this study was to ascertain antibiotic resistance patterns and prevalence of MBL genes in clinical isolates of P. aeruginosa. Materials & Methods:   In total, ۹۰ non-repetitive clinical isolates of P. aeruginosa were collected from clinical specimens of patients who referred to Amir Al-Momenin hospital in Zabol, southeast of Iran, from January ۲۰۱۹ to November ۲۰۲۲. Antibiotic susceptibility patterns were determined according to CLSI guidelines. Combined disk test (CDT) was used to detect MBL-producing P. aeruginosa isolates. MBL genes (blaIMP, blaVIM, blaNDM, and blaSPM) were detected by PCR (polymerase chain reaction) method. Findings: The isolates were mostly resistant to ceftriaxone (۵۱.۱%, ۴۶ of ۹۰) and gentamicin (۴۳.۳%, ۳۹ of ۹۰). Based on CDT results, ۸۹.۴% (۱۷ of ۱۹) of carbapenem-resistant isolates were MBL positive. In addition, MBL genes including blaVIM, blaIMP, and blaNDM were detected in ۲۰% (۱۸ of ۹۰), ۸.۹% (۸ of ۹۰), and ۵.۶% (۵ of ۹۰) of the isolates, respectively. Conclusions: Based on this study findings, the use of ceftriaxone and gentamicin should be restricted. In addition, MBL genes (blaVIM and blaIMP) seem to play a crucial role in the spread of carbapenem-resistant infections and the emergence of multidrug-resistant isolates, leading to antibiotic treatment failure.

نویسندگان

Hamid Vaez

Department of Microbiology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran

Zahra Yazdanpour

Department of Microbiology, School of medicine, Zabol University of Medical Sciences, Zabol, Iran

Farzad Khademi

Department of Microbiology, School of medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Abbas Pishdadian

Department of Immunology, School of medicine, Zabol University of Medical Sciences, Zabol, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • References۱. Tenover FC, Nicolau DP, Gill CM. Carbapenemase-producing Pseudomonas aeruginosa ...
  • Qin S, Xiao W, Zhou C, Pu Q, Deng X, ...
  • Rebold N, Rybak MJ. Therapeutic strategies for emerging multidrug-resistant Pseudomonas ...
  • Verdial C, Serrano I, Tavares L, Gil S, Oliveira M. ...
  • Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, ...
  • Vaez H, Salehi-Abargouei A, Ghalehnoo ZR, Khademi F. Multidrug resistant ...
  • Vaez H, Salehi-Abargouei A, Khademi F. Systematic review and meta-analysis ...
  • Vaez H, Khademi F, Salehi-Abargouei A, Sahebkar A. Metallo-beta-lactamase-producing Pseudomonas ...
  • Subedi D, Vijay AK, Willcox M. Overview of mechanisms of ...
  • Mahon C, Lehman, D, Manuselis G. Text book of diagnostic ...
  • Clinical and Laboratory Standards Institute. CLSI supplement M۱۰۰: Performance standards ...
  • Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, ...
  • Safarirad S, Arzanlou M, Mohammadshahi J, Vaez H, Sahebkar A, ...
  • Delarampour A, Ghalehnoo ZR, Khademi F, Delarampour M, Vaez H. ...
  • Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR ...
  • Khademi F, Ashrafi SS, Neyestani Z, Vaez H, Sahebkar A. ...
  • Rahman MM, Alam Tumpa MA, Zehravi M, Sarker MT, Yamin ...
  • Bazghandi SA, Arzanlou M, Peeridogaheh H, Vaez H, Sahebkar A, ...
  • Nikokar I, Tishayar A, Flakiyan Z. Antibiotic resistance and frequency ...
  • Radan M, Moniri R, Khorshidi A, Gilasi H, Norouzi Z, ...
  • Talebi-Taher M, Majidpour A, Gholami A, Rasouli-Kouhi S, Adabi M. ...
  • European Centre for Disease Prevention and Control. Surveillance of antimicrobial ...
  • Mirbagheri SZ, Meshkat Z, Naderinasab M, Rostami S, Nabavinia MS, ...
  • Khorvash F, Yazdani MR, Shabani S, Shabani S, Alizadeh H, ...
  • Jean SS, Harnod D, Hsueh PR. Global threat of carbapenem-resistant ...
  • Castro-Sánchez E, Moore LS, Husson F, Holmes AH. What are ...
  • Dávalos-Almeyda M, Guerrero A, Medina G, Dávila-Barclay A, Salvatierra G, ...
  • Shariati A, Azimi T, Ardebili A, Chirani AS, Bahramian A, ...
  • Vaez H, Sahebkar A, Khademi F. Carbapenem-resistant Klebsiella pneumoniae in ...
  • Saha K, Kabir ND, Islam MR, Amin MB, Hoque KI, ...
  • Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, ...
  • نمایش کامل مراجع